Malaria is one of the most devastating human infectious diseases caused by Plasmodium
spp. parasites. A search for an effective and safe vaccine is the main challenge for its …

Malaria caused by Plasmodium vivax continues being one of the most important infectious
diseases around the world; P. vivax is the second most prevalent species and has the …

Background As Zika virus continues to spread, decisions regarding resource allocations to
control the outbreak underscore the need for a tool to weigh policies according to their cost …

Historically seen as a benign disease, it is now becoming clear that Plasmodium vivax can
cause significant morbidity. Effective control strategies targeting P. vivax malaria is hindered …

Abstract Development of a protective and broadly-acting vaccine against the most widely
distributed human malaria parasite, Plasmodium vivax, will be a major step towards malaria …

A randomized, double-blind, controlled vaccine clinical trial was conducted to assess, as the
primary outcome, the safety and protective efficacy of the Plasmodium vivax …

Synthetic peptide vaccines provide the advantages of safety, stability and low cost. The
success of this approach is highly dependent on efficient epitope identification and synthetic …

Summary Geographical Information Systems (GIS) have been used extensively for the
development of epidemiological maps of malaria but not in the Coffee Triangle region of …

The circumsporozoite protein (CSP) of the malaria parasite Plasmodium vivax is a major pre-
erythrocyte vaccine candidate. The protein has a central repeat region that belongs to one of …

Plasmodium vivax is the most widespread species of Plasmodium, causing up to 50% of the
malaria cases occurring outside sub-Saharan Africa. An effective vaccine is essential for …